Financhill
Back

GT Biopharma Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
55

GTBP
GT Biopharma

Last Price:
2.95
Seasonality Move:
-2.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

GT Biopharma Stock Forecast

  • Is GT Biopharma Stock Undervalued?
    The current GT Biopharma [GTBP] share price is $2.97. The Score for GTBP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • GTBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will GT Biopharma Stock Go Up Next Year?

Data Unavailable

GT Biopharma Stock Rating

Data Unavailable

GT Biopharma Stock Price History

Is GTBP stock going to rise?

  • The current trend is moderately bullish and GTBP is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
gtbiopharma.com

52-Week Data

52-Week High:
10.66
52-Week Low:
1.92

Prediction Charts

Market Cap:
6.64M
Price in USD:
2.97
Volume:
3.88K
Beta:
1.35

Technical Analysis

SMA50:
2.28
SMA100:
2.48
SMA200:
3.39
52-Wk Change:
-60.4%

Stock Predictions

  • Is GT Biopharma stock public?
    Yes, GT Biopharma is a publicly traded company.
  • What is the GT Biopharma stock quote today?
    The GT Biopharma stock price is 2.97 USD today.
  • How to buy GT Biopharma stock online?
    You can buy GT Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-14 2.02 2.05 2.05 2.00
Oct-15 2.01 1.96 2.04 1.95
Oct-16 1.97 2.00 2.00 1.97
Oct-18 2.11 2.29 2.34 2.04
Oct-21 2.29 2.42 2.58 2.26
Oct-22 2.43 2.54 2.56 2.43
Oct-23 2.54 2.95 2.96 2.54
Oct-24 3.02 3.02 3.55 2.80
Oct-25 3.00 3.12 3.12 2.92
Oct-28 3.19 3.29 3.30 3.01
Oct-29 3.23 3.33 3.37 3.10
Oct-30 3.23 3.01 3.30 3.01
Oct-31 2.97 2.97 3.01 2.85
Nov-1 2.95 2.97 3.00 2.88

GT Biopharma Earnings

Data Unavailable

GT Biopharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.

* GT Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.